跳至主要内容
临床试验/NCT01126931
NCT01126931Unknown不适用

Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age

University Hospital Freiburg1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2006年2月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
Improvement in appetite

研究概览

简要总结

Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer.

Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite

详细描述

Supplementation with wormwood in chronic disorders associated with reduced appetite.

Examples:

  1. Cancer
  2. Autoimmune diseases such as Crohns disease and IgA Nephropathy
  3. Old age
  4. Chronic stress and depression

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Appetite and weight loss
  • Chronic progressive disease

排除标准

  • Life expectancy less than 3 months

结局指标

主要结局

Improvement in appetite

时间窗: 6-12 months

次要结局

  • Improvement in quality of life(12-24 months)

研究者

发起方
University Hospital Freiburg
申办方类型
Other

研究点 (1)

Loading locations...

相似试验